Evidence Note: Evidence strength varies by condition. Chronic pain and epilepsy have the strongest clinical evidence base. Other conditions are treated based on specialist clinical judgement and emerging research. All prescriptions require specialist assessment.
Attention deficit hyperactivity disorder (ADHD) affects an estimated 2.6 million adults in the United Kingdom. Characterised by persistent inattention, hyperactivity, and impulsivity, adult ADHD causes significant impairment in professional, social, and personal functioning. While stimulant medications (methylphenidate, lisdexamfetamine) are effective for many patients, a substantial proportion experience inadequate symptom control, intolerable side effects, or have contraindications to standard treatment.
The Endocannabinoid System and ADHD
Research suggests that endocannabinoid system dysfunction may contribute to ADHD pathophysiology. The endocannabinoid system is deeply involved in dopamine regulation — the neurotransmitter system most implicated in ADHD — and plays a role in executive function, working memory, and impulse control. Cannabis may modulate dopaminergic tone in the prefrontal cortex in ways that complement or parallel stimulant mechanisms.
Clinical Evidence for Cannabis in ADHD
A 2020 observational study published in the Journal of Attention Disorders found that ADHD patients using cannabis reported significant improvements in inattention and hyperactivity-impulsivity scores, along with reductions in anxiety and sleep problems — domains commonly comorbid with ADHD. A 2021 placebo-controlled pilot study of Sativex in adult ADHD demonstrated improvements in cognitive measures and emotional dysregulation.
Some patients report improved focus with low-dose protocols
Frequently Asked Questions
Can medical cannabis be prescribed for ADHD in the UK?
Yes. A GMC-registered psychiatrist or specialist cannabis clinician can prescribe cannabis-based medicines for ADHD in adults where standard treatments (methylphenidate, lisdexamfetamine) have proven inadequate or are not tolerated. Self-referral to a cannabis clinic is permitted; a GP referral is not required.
Will medical cannabis interact with my ADHD medication?
Cannabinoids may interact with stimulant medications. CBD can inhibit CYP2D6 and CYP3A4 enzymes involved in the metabolism of some stimulants. Cannabis is generally not combined with MAOI antidepressants. Your prescribing specialist will review your full medication list before initiating treatment. Some patients use cannabis as an alternative to stimulants rather than alongside them.
Is CBD or THC better for ADHD?
Most UK specialists use CBD-dominant preparations for ADHD, particularly where anxiety is prominent. CBD provides anxiolytic and focus-supporting effects without psychoactive impairment. Low-dose THC may be added for patients with significant sleep disturbance or where CBD alone provides insufficient benefit. High-THC preparations are generally avoided due to potential impairment of executive function.
Does medical cannabis improve focus and concentration in ADHD?
Some patients with ADHD report improved focus and reduced mental restlessness with low-dose cannabis protocols. The evidence base remains early, with small trials showing improvements in cognitive and emotional dysregulation measures. Cannabis is unlikely to replicate the direct dopaminergic effects of stimulant medications but may address comorbid anxiety and sleep issues that amplify ADHD symptoms.
Ready to Explore Your Options?
Our GMC-registered specialists assess each patient individually. Book a consultation to discuss whether medical cannabis is appropriate for your condition.
